FDC (NSE:FDC) Interest Coverage : 75.77 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is FDC Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. FDC's Operating Income for the three months ended in Dec. 2023 was ₹738 Mil. FDC's Interest Expense for the three months ended in Dec. 2023 was ₹-10 Mil. FDC's interest coverage for the quarter that ended in Dec. 2023 was 75.77. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. FDC Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for FDC's Interest Coverage or its related term are showing as below:

NSE:FDC' s Interest Coverage Range Over the Past 10 Years
Min: 59.82 Med: 108.71 Max: 211.04
Current: 80.82

NSE:FDC's Interest Coverage is ranked better than
76.83% of 682 companies
in the Drug Manufacturers industry
Industry Median: 12.275 vs NSE:FDC: 80.82

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

FDC Interest Coverage Historical Data

The historical data trend for FDC's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

FDC Interest Coverage Chart

FDC Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Coverage

Get a 7-Day Free Trial

183.11

92.95

107.02

86.64

59.82

FDC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Coverage	Get a 7-Day Free Trial															32.90	75.04	107.30	62.81	75.77

Competitive Comparison of FDC's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, FDC's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FDC's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FDC's Interest Coverage distribution charts can be found below:

* The bar in red indicates where FDC's Interest Coverage falls into.

FDC Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

FDC's Interest Coverage for the fiscal year that ended in Mar. 2023 is calculated as

Here, for the fiscal year that ended in Mar. 2023, FDC's Interest Expense was ₹-36 Mil. Its Operating Income was ₹2,136 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹208 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Mar. 2023 )	/	Interest Expense (A: Mar. 2023 )
	=	-1	*	2136.329	/	-35.715
	=	59.82

FDC's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the three months ended in Dec. 2023, FDC's Interest Expense was ₹-10 Mil. Its Operating Income was ₹738 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹0 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	738.151	/	-9.742
	=	75.77

The higher the ratio, the stronger the company's Financial Strength is.

FDC (NSE:FDC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

FDC Interest Coverage Related Terms

Thank you for viewing the detailed overview of FDC's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

FDC (NSE:FDC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Interest Coverage

Traded in Other Exchanges

531599:India

Address

C-3 Skyvistas, Near Versova Police Station, D.N. Nagar, Andheri (West), Mumbai, MH, IND, 400053

Website

https://www.fdcindia.com

FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.